Because the study population included women with prolactin excess of different origin: subjects with microprolactinoma, drug-induced prolactin excess, traumatic brain injury, empty sella syndrome and idiopathic hyperprolactinemia, the increased risk does not seem to depend on the underlying condition. This evidence concerns the gene PRL and Increased circulating prolactin concentration.